Opipramol inhibits lipolysis in human adipocytes without altering glucose uptake and differently from antipsychotic and antidepressant drugs with adverse effects on body weight control

  1. Carpéné, C.
  2. Les, F.
  3. Mercader, J.
  4. Gomez‐zorita, S.
  5. Grolleau, J.-L.
  6. Boulet, N.
  7. Fontaine, J.
  8. Iglesias‐osma, M.C.
  9. Garcia‐barrado, M.J.
Zeitschrift:
Pharmaceuticals

ISSN: 1424-8247

Datum der Publikation: 2020

Ausgabe: 13

Nummer: 3

Art: Artikel

DOI: 10.3390/PH13030041 GOOGLE SCHOLAR lock_openOpen Access editor

Ziele für nachhaltige Entwicklung